Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase III Study of the Prognostic Significance of Occult Metastases in Patients With Resectable Non-Small Cell Lung Cancer

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
Phase III	Diagnostic	Closed	18 and over	NCI	ACOSOG-Z0040 ACOSOG-Z0040, NCT00003901

Trial Description

Purpose:

Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment.

Phase III trial to study the relationship between early signs of metastases and survival in patients who have stage I, stage II, or stage III non-small cell lung cancer that can be removed by surgery.

Eligibility:

• At least 18 years old
• No previous chemotherapy or radiation therapy for non-small cell lung cancer
• At least 5 years since surgery on the opposite lung
• Surgery planned to remove the tumor
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo surgery to have lymph nodes and a small portion of rib removed. Some patients will also have the tumor removed. Lymph nodes and bone marrow from the rib will be examined for signs of metastases. Patients will receive follow-up evaluations for 5 years.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

American College of Surgeons Oncology Group

Robbin Cohen, MD, Protocol chair		Ph: 323-442-5849; 800-865-0102 Email: rcohen@usc.edu

Registry Information
Official Title		A Prospective Study of the Prognostic Significance of Occult Metastases in the Patient with Resectable Non-Small Cell Lung Carcinoma
Trial Start Date		1999-07-13
Registered in ClinicalTrials.gov		NCT00003901
Date Submitted to PDQ		1999-05-07
Information Last Verified		2004-10-18
NCI Grant/Contract Number		CA76001

Back to Top